{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:29:22Z","timestamp":1780568962652,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1067\/mjd.2002.126579","type":"journal-article","created":{"date-parts":[[2003,5,27]],"date-time":"2003-05-27T23:08:28Z","timestamp":1054076908000},"page":"S212-S216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S","title":["Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions"],"prefix":"10.1067","volume":"47","author":[{"given":"Daniel","family":"Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"vander Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.126579_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infections","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mjd.2002.126579_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/1097-0142(19850515)55:10<2437::AID-CNCR2820551023>3.0.CO;2-Z","article-title":"Primary tissue culture of spontaneously regressing flat warts","volume":"55","author":"Tagami","year":"1985","journal-title":"Cancer"},{"key":"10.1067\/mjd.2002.126579_bib3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ajcp\/102.6.768","article-title":"Immunological events in regressing genital warts","volume":"102","author":"Coleman","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1067\/mjd.2002.126579_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jir.1996.16.453","article-title":"Activation of local cell-mediated immunity in interferon-response patients with human papillomavirus-associated lesions","volume":"16","author":"Arany","year":"1996","journal-title":"J Interferon Cytokine Res"},{"key":"10.1067\/mjd.2002.126579_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","article-title":"Treatment of genital warts with an immune-response modifier (imiquimod)","volume":"38","author":"Beutner","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.126579_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.126579_bib7","unstructured":"Owens ML, Tygum KI, Senta TA, Myers JA, Fox TL, Smith MH. A safety assessment of topical imiquimod [abstract]. Presented at the 19th World Congress of Dermatology; 1997 June 15-20; Sydney, Australia."},{"key":"10.1067\/mjd.2002.126579_bib8","unstructured":"Beutner K, Edwards L, Tyring S, Ferenczy A, Owens M, Fox T, Hougham A, et al. Comparison of results from two vehicle controlled clinical trials of topical imiquimod for the treatment of genital\/perianal warts [abstract]. Presented at the American Academy of Dermatology 54th Annual Meeting; 1996 Mar 10-15; Washington, DC."},{"key":"10.1067\/mjd.2002.126579_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1067\/mjd.2002.126579_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/517472","article-title":"A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod","volume":"178","author":"Tyring","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1067\/mjd.2002.126579_bib11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(92)91339-C","article-title":"Superficial laser vulvectomy V. Surgical debulking is enhanced by adjuvant systemic interferon","volume":"166","author":"Reid","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mjd.2002.126579_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jir.1994.14.81","article-title":"Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro","volume":"14","author":"Weeks","year":"1994","journal-title":"J Interferon Res"},{"key":"10.1067\/mjd.2002.126579_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/jir.1995.15.537","article-title":"Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609","volume":"15","author":"Gibson","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1067\/mjd.2002.126579_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jlb.58.3.365","article-title":"Cytokine induction by the immunomodulators imiquimod and S-27609","volume":"58","author":"Testerman","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1067\/mjd.2002.126579_bib15","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/MCB.15.4.2207","article-title":"Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by sendai virus utilize similar signal transduction pathways","volume":"15","author":"Megyeri","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1067\/mjd.2002.126579_bib16","first-page":"405","article-title":"Imiquimod: in vivo and in vitro characteristics and toxicology","author":"Tomai","year":"1997"},{"key":"10.1067\/mjd.2002.126579_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1523-1747.1998.00174.x","article-title":"Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463","volume":"110","author":"Imbertson","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.126579_bib18","first-page":"566","article-title":"Imiquimod, a novel topical immune response modifier induces migration of Langerhans' cells [abstract]","volume":"110","author":"Suzuki","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.126579_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-3542(99)00052-2","article-title":"Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod","volume":"44","author":"Miller","year":"1999","journal-title":"Antiviral Res"},{"key":"10.1067\/mjd.2002.126579_bib20","first-page":"51","article-title":"Treatment of experimental viral infections with immunomodulators","volume":"68","author":"Kende","year":"1988","journal-title":"Adv Biosci"},{"issue":"Suppl 2","key":"10.1067\/mjd.2002.126579_bib21","first-page":"S62","article-title":"STAT-1 is a key target for imiquimod, an oral inducer of interferon [abstract]","volume":"17","author":"Bottrel","year":"1997","journal-title":"J Interferon Cytokine Res"},{"key":"10.1067\/mjd.2002.126579_bib22","first-page":"3528","article-title":"Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine","volume":"52","author":"Sidky","year":"1992","journal-title":"Cancer Res"},{"key":"10.1067\/mjd.2002.126579_bib23","first-page":"651","article-title":"Effects of the imidazoquinolines, imiquimod and S-28463, on Th1 and Th2 cytokine responses in vitro [abstract]","volume":"110","author":"Tomai","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.126579_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1084\/jem.185.5.825","article-title":"Selective expression of an interleukin-12 receptor component by human T helper 1 cells","volume":"185","author":"Rogge","year":"1997","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.126579_bib25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.185.5.817","article-title":"Regulation of the interleukin (IL)-12R \u03b22 subunit expression in developing T helper 1 (Th1) and (Th2) cells","volume":"185","author":"Szabo","year":"1997","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2002.126579_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/167.3.731","article-title":"Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs","volume":"167","author":"Bernstein","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1067\/mjd.2002.126579_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0264-410X(95)80014-5","article-title":"Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea pigs","volume":"13","author":"Bernstein","year":"1995","journal-title":"Vaccine"},{"key":"10.1067\/mjd.2002.126579_bib28","first-page":"258","article-title":"Mechanisms of anti-tumor action of the interferon inducer R-837 [abstract]","volume":"32","author":"Borden","year":"1991","journal-title":"Proc Am Assoc Cancer Res"},{"key":"10.1067\/mjd.2002.126579_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jlb.55.2.234","article-title":"Cytokine induction in mice by the immunomodulator imiquimod","volume":"55","author":"Reiter","year":"1994","journal-title":"J Leukoc Biol"},{"key":"10.1067\/mjd.2002.126579_bib30","first-page":"148","article-title":"Cytokine-induction by imiquimod, preclinical results and pharmacology","volume":"4","author":"Miller","year":"1994","journal-title":"Chemotherapie J"},{"key":"10.1067\/mjd.2002.126579_bib31","unstructured":"Conant MA, Opp KM, Gilson RJC, Shupack JL, Friedman-Kien AE, Owens ML, et al. A vehicle-controlled safety and efficacy trial evaluating 5% imiquimod cream for the treatment of genital\/perianal warts in HIV-positive patients [abstract]. Presented at the American Academy of Dermatology 56th Annual Meeting; 1998 Feb 27-Mar 4; Orlando, Florida."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202001160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202001160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:25:20Z","timestamp":1759267520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0190962202001160"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.126579","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2002.126579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}